(Q40395443)

20 September 2017

title

Immunity to melanoma mediated by 4-1BB is associated with enhanced activity of tumour-infiltrating lymphocytes (English)

1 reference

20 September 2017

Seong-A Ju

1

1 reference

20 September 2017

Sang-Chul Lee

2

1 reference

20 September 2017

Tae-Hyoung Kwon

3

1 reference

20 September 2017

Sook-Kyoung Heo

4

1 reference

20 September 2017

Sang-Min Park

5

1 reference

20 September 2017

Ha-Na Paek

6

1 reference

20 September 2017

Jae-Hee Suh

7

1 reference

20 September 2017

Hong Rae Cho

8

1 reference

20 September 2017

Byungsuk Kwon

9

1 reference

20 September 2017

Byoung S Kwon

10

1 reference

20 September 2017

Byung-Sam Kim

11

1 reference

20 September 2017

publication date

1 August 2005

1 reference

Immunology & Cell Biology

20 September 2017

published in

1 reference

20 September 2017

volume

83

1 reference

20 September 2017

issue

4

1 reference

20 September 2017

page(s)

344-351

1 reference

Role of 4-1BB in immune responses.

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01330.X

4-1BB-specific monoclonal antibody promotes the generation of tumor-specific immune responses by direct activation of CD8 T cells in a CD40-dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01330.X

Immunotherapy of human papillomavirus-associated malignancies and the challenges posed by T-cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01330.X

NK1.1 cells express 4-1BB (CDw137) costimulatory molecule and are required for tumor immunity elicited by anti-4-1BB monoclonal antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01330.X

Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01330.X

Cellular responses to interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01330.X

Immune responses in 4-1BB (CD137)-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01330.X

Rejection of disseminated metastases of colon carcinoma by synergism of IL-12 gene therapy and 4-1BB costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01330.X

Modulation of the immune response through 4-1BB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01330.X

In vivo stimulation of CD137 broadens primary antiviral CD8+ T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01330.X

Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01330.X

cDNA cloning and interferon gamma down-regulation of proteasomal subunits X and Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01330.X

10.1111/J.1440-1711.2005.01330.X

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference